Jaguar Health, Inc. Purchase Agreements
27 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on May 9, 2023)
- Securities Purchase Agreement, dated November 11, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation (Filed With SEC on November 16, 2022)
- Royalty Interest Purchase Agreement, dated August 24, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on August 30, 2022)
- Securities Purchase Agreement, dated August 18, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation (Filed With SEC on August 23, 2022)
- Securities Purchase Agreement, dated September 13, 2021, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on September 17, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on April 30, 2021)
- First Amendment to the Equity Purchase Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)
- Securities Purchase Agreement, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on March 11, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 14, 2021)
- Securities Purchase Agreement, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC (Filed With SEC on December 29, 2020)
- Royalty Interest Purchase Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)
- First Amendment to Purchase Agreement, dated June 26, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on August 13, 2020)
- First Amendment to Royalty Interest Purchase Agreement and Related Documents, dated July 10, 2020, between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on July 14, 2020)
- Purchase Agreement, dated May 12, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on May 21, 2020)
- Purchase Agreement, dated April 15, 2020, by and between Napo Pharmaceuticals, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)
- Equity Purchase Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on March 26, 2020)
- Securities Purchase Agreement, dated March 23, 2020, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on March 26, 2020)
- Securities Purchase Agreement, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on March 6, 2020)
- Securities Purchase Agreement, dated December 20, 2019, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on December 26, 2019)
- Securities Purchase Agreement, dated November 13, 2019, by and between Jaguar Health, Inc. and the purchasers named therein (Filed With SEC on November 14, 2019)
- Securities Purchase Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and the Investor (Filed With SEC on March 25, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on March 22, 2019)
- Securities Purchase Agreement, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on March 27, 2018)
- Securities Purchase Agreement, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on March 2, 2018)
- Securities Purchase Agreement, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on December 14, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 3, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 29, 2016)